Ignite Creation Date:
2025-12-25 @ 4:30 AM
Ignite Modification Date:
2025-12-26 @ 3:33 AM
Study NCT ID:
NCT01539018
Status:
TERMINATED
Last Update Posted:
2015-08-05
First Post:
2012-02-21
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Sorafenib Plus Tegafur-uracil (UFT) Versus Sorafenib as First Line Systemic Treatment for Patients With Advanced Stage HCC, Unresectable & Not Eligible for Local Ablation and/or TACE
Sponsor:
Egyptian Society of Liver Cancer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-01
Start Date Type:
None
Primary Completion Date:
2015-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-01
Completion Date Type:
ACTUAL
First Submit Date:
2012-02-21
First Submit QC Date:
None
Study First Post Date:
2012-02-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-08-03
Last Update Post Date:
2015-08-05
Last Update Post Date Type:
ESTIMATED